Three-year follow-up of patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) receiving ibrutinib plus bendamustine and rituximab (BR) versus placebo plus BR: an update of the HELIOS study

---

Copy For Citation

Hallek M., Fraser G., Cramer P., DEMİRKAN F., Silva R. S., Grosicki S., ...More

LEUKEMIA & LYMPHOMA, vol.58, pp.192-194, 2017 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 58
• Publication Date: 2017
• Journal Name: LEUKEMIA & LYMPHOMA
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
• Page Numbers: pp.192-194
• Dokuz Eylül University Affiliated: Yes